15/05/2026
Recent scientific research has unveiled a surprising chemical complexity within cannabis leaves, traditionally viewed as harvest waste and discarded after focusing on cannabinoid-rich flowers.
A study from Stellenbosch University identified 79 phenolic compounds in leaves from three commercial strains, including 25 never before reported in cannabis and 16 rare flavoalkaloids—a class of hybrid flavonoid-alkaloid molecules seldom found in nature.
These compounds, concentrated more in leaves than flowers in certain strains, expand beyond well-known THC and CBD. Phenolic molecules like flavonoids often exhibit potent antioxidant, anti-inflammatory, and potentially anti-carcinogenic effects, supporting broader therapeutic applications.
While cannabinoids dominate research for pain relief, epilepsy, and nausea, this hidden chemistry suggests leaves could yield novel treatments for oxidative stress, inflammation, and other conditions through synergistic plant interactions.
Variation across strains highlights untapped biodiversity, urging further isolation, testing, and clinical trials. No human benefits are proven yet, but the findings challenge waste norms, promoting sustainable use of the entire plant.
This discovery underscores cannabis as a phytochemical powerhouse, potentially revolutionizing medicine by unlocking rare molecules overlooked for decades. Exploring leaf extracts could diversify natural therapies, reducing reliance on synthetic drugs while advancing holistic health solutions.